Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FHM54
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,526
Award facts
- Contract value 100% obligated
- $26,525.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $26,525.70 and an ultimate completion date of July 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is an immuno-oncology pharmaceutical used in cancer treatment, representing the type of specialized therapeutic medication that DLA procures to support military healthcare systems.
This delivery order is part of AmerisourceBergen's extensive federal contracting relationship with DLA, leveraging its $999,999,999.00 IDC valued through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet stringent federal procurement requirements and positions it as a critical vendor within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FHM54?
SPE2DB25FHM54 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FHM54 worth?
The government has obligated $26,526 on SPE2DB25FHM54.
Is contract SPE2DB25FHM54 an order under another contract?
Yes. SPE2DB25FHM54 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHM54 competed?
The extent of competition for SPE2DB25FHM54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award